Propranolol in Prevention of Rebleeding from Oesophageal Varices during the Course of Endoscopic Sclerotherapy

References

• Terblanche J, Yakoob H I, Bornman P C, Stiege-Mann G V, Bane R, Jonker M, Wright J, et al. Acute bleeding varices. A five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg 1981; 194: 521–530
   PubMed Web of Science ®Google Scholar
• Fleig W E, Stange E F, Reuttenauer K, Ditschuneit H. Emergency endoscopic sclerotherapy for bleeding esophageal varices: a prospective study in patients not responding to balloon tamponade. Gastroinest Endosc 1983; 29: 8–14
   Google Scholar
• Paquet K J, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices. Prospective controlled randomized trial. Hepatology 1985; 5: 580–583
   PubMed Web of Science ®Google Scholar
• MacDougall B RD, Westaby D, Theodossi A, Daw-Son J L, Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Lancet 1982; 1: 124–127
   PubMed Web of Science ®Google Scholar
• EVASP. Sclerotherapy after first variceal haemorrhage in cirrhosis. A randomized Danish multi-center trial. N Engl J Med 1984; 311: 1594–1600
   PubMed Web of Science ®Google Scholar
• Westaby D, MacDougall B RD, Williams R. Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology 1985; 5: 827–830
   PubMed Web of Science ®Google Scholar
• Korula J, Balart L A, Radvan G, Zweiban B E, Larson A W, Kao H W, Yamada S. A prospective randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 1985; 5: 584–589
   PubMed Web of Science ®Google Scholar
• Soderlund C. Long-term survivors after variceal haemorrhage. Follow-up of a controlled study of endoscopic sclerotherapy versus conservative management. Scand J Gastroenterol 1987; 22: 665–671
   PubMed Web of Science ®Google Scholar
• Westaby D, Mella M W, MacDougall B RD, Hegarty J E, Williams R. Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules. Gut 1984; 25: 129–132
   PubMed Web of Science ®Google Scholar
• Sørensen T IA, Burcharth F, Pedersen M L, Lindahl F. Oesphageal stricture and dysphagia after endoscopic sclerotherapy for bleeding varices. Gut 1984; 25: 473–477
   PubMed Web of Science ®Google Scholar
• Pascal J P, Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987; 317: 856–861
   PubMed Web of Science ®Google Scholar
• Lebrec D, Poynard T, Bernuau J, Bercoff E, Nouel O, Capron J-P, Bouvry M, et al. A randomized controlled study of propranolol for prevention of recurrent gastrotinestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355–358
   PubMed Web of Science ®Google Scholar
• Borroughs A K, Jenkins W J, Sherlock S, Dunk A, Walt R P, Osuafor T OK, Mackie S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539–1542
   PubMed Web of Science ®Google Scholar
• Villeneuve J P, Pomier-Layrargues G, Infante Rivard C, Willems B, Huet P M, Marleau D, Viallet A. Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology 1986; 6: 1239–1243
   PubMed Web of Science ®Google Scholar
• Child C G. The liver and portal hypertension. W. B. Saunders, Philadelphia 1964; 50
   Google Scholar
• Pugh R NH, Murray-Lyon I M, Dawson J L, Pietroni M C, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–649
   PubMed Web of Science ®Google Scholar
• Dagradi A E, Stempien S J, Owens L K. Bleeding esophagogastric varices. An endoscopic study of 50 cases. Arch Surg 1966; 92: 944–947
   PubMedGoogle Scholar
• Westaby D, Melia W, Hegarty J, Gimson A ES, Stellon A J, Williams R. Use of propranolol to reduce the rebleeding rate during injection sclero-therapy prior to variceal obliteration. Hepatology 1986; 6: 673–675
   PubMed Web of Science ®Google Scholar
• Lebrec D, DeFleury P, Reuff B, Nahum H, Benhamou J P. Portal hypertension, size of esopha-geal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980; 79: 1139–1144
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Groszmann R J, Fisher R L, Conn H O, Atterbury C E, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419–424
   PubMed Web of Science ®Google Scholar
• Graham D Y, Smith J L. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800–809
   PubMed Web of Science ®Google Scholar
• Leahey W J, Neill J D, Varma M PS, Shanks R G. Comparison of the efficacy and pharmacokinetics of conventional propranolol and long acting preparation of propranolol. Br J Clin Pharmacol 1980; 9: 33–40
   PubMed Web of Science ®Google Scholar
• Bosch J, Masti R, Kravetz D, Bruix J, Gaya J, Rigau J, Rodes J. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemo-dynamics in cirrhosis. Hepatology 1984; 4: 1200–1205
   PubMed Web of Science ®Google Scholar
• Jensen L S, Krarup N, Juhl C O, Nielsen T H, Larsen J A. Endoscopic, portographic and hemodynamic evaluation of prolonged propranolol administration in pigs with experimental portal hypertension and esophageal varices. Scand J Gastroenterol 1989; 24: 213–222
   PubMed Web of Science ®Google Scholar
• Marbet U A, Straumann A, Gyr K E, Beglinger C, Schaub N, Vögtlin J, Loosli J, et al. Reduction in early recurrences of variceal bleeding by propranolol. Scand J Gastroenterol 1988; 23: 369–374
   PubMed Web of Science ®Google Scholar